Fig. 2From: The serum protein responses to treatment with Xiaoke Pill and Glibenclamide in type 2 diabetes patientsQuality control of proteomics analysis data. a Left panel SDS-PAGE for the serum without treatment by ProteoMiner; Right panel SDS-PAGE for the serum treated with ProteoMiner. b Reproducibility of the proteins identified in MS/MS duplicates. c The quantitative correlation analysis for the tag intensities 117 versus 113 (X AN /X BN )Back to article page